Breathlessness or shortness of breath (SOB) can be a short-term or long-term side effect after surgery, particularly lobectomy, for patients with NSCLC. There is good evidence now to support use […] Read more
On May 28, the US Food and Drug Administration (FDA) granted accelerated approval of sotorasib for patients with KRAS G12C-mutated NSCLC who have received at least one prior line of […] Read more